PDF
Word
Egrifta Tesamoralin Patient Treatment Request - Nevada
Egrifta Tesamoralin Patient Treatment Request is a legal document that was released by the Nevada Department of Health and Human Services - a government authority operating within Nevada.
FAQ
Q: What is Egrifta Tesamoralin?
A: Egrifta Tesamoralin is a medication used for the long-term treatment of excess abdominal fat in HIV-infected patients with lipodystrophy.
Q: Who can request Egrifta Tesamoralin patient treatment in Nevada?
A: Patients with HIV infection and lipodystrophy can request Egrifta Tesamoralin patient treatment in Nevada.
Q: What is the purpose of Egrifta Tesamoralin?
A: Egrifta Tesamoralin is used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.
Q: Is Egrifta Tesamoralin approved by the FDA?
A: Yes, Egrifta Tesamoralin is approved by the FDA for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy.
Q: Are there any side effects of Egrifta Tesamoralin?
A: Yes, common side effects of Egrifta Tesamoralin include injection site reactions, muscle or joint pain, and swelling.
Form Details:
- The latest edition currently provided by the Nevada Department of Health and Human Services;
- Ready to use and print;
- Easy to customize;
- Compatible with most PDF-viewing applications;
- Fill out the form in our online filing application.
Download a fillable version of the form by clicking the link below or browse more documents and templates provided by the Nevada Department of Health and Human Services.
Download Egrifta Tesamoralin Patient Treatment Request - Nevada
1
2
